Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC. Walia A, Prasad V. J Cancer Res Clin Oncol 2023;149:9513-9515.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Walia A, Prasad V. Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC. J Cancer Res Clin Oncol 2023;149:9513-9515.
PMID: 37178425